Allen Wealth Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.11M Buy
24,474
+2,619
+12% +$231K 1.03% 16
2026
Q2
$1.71M Sell
21,855
-299
-1% -$24.1K 0.83% 28
2026
Q1
$1.92M Buy
22,154
+620
+3% +$59.4K 0.96% 23
2025
Q4
$2.07M Buy
21,534
+157
+0.7% +$15.2K 1.24% 19
2025
Q3
$2.04M Sell
21,377
-286
-1% -$26.3K 1.38% 15
2025
Q2
$1.89M Buy
21,663
+359
+2% +$30.4K 1.32% 15
2025
Q1
$1.91M Buy
21,304
+389
+2% +$34.8K 1.32% 16
2024
Q4
$1.67M Buy
20,915
+1,324
+7% +$115K 1.2% 18
2024
Q3
$1.76M Buy
19,591
+2,097
+12% +$176K 1.22% 21
2024
Q2
$1.38M Buy
17,494
+1,138
+7% +$93.3K 1.23% 20
2024
Q1
$1.43M Buy
+16,356
New +$1.4M 1.26% 20

Other funds holding MDT

Allen Wealth Management's MDT Position: Q3 2026 in Review

Allen Wealth Management increased its Medtronic (MDT) stake by 12% in Q3 2026, buying an estimated $231K and bringing the position to 24,474 shares worth $2.11M. The position accounts for 1.03% of the portfolio, ranked #16.

Allen Wealth Management first reported a position in MDT in Q1 2024 and has held it in 11 quarters since. 917 funds tracked by Wall St. Rank hold MDT as of Q3 2026.

  • Allen Wealth Management held 24,474 shares of Medtronic worth $2.11M as of Q3 2026.
  • Allen Wealth Management bought 2,619 Medtronic shares in Q3 2026, an estimated $231K.
  • Medtronic made up 1.03% of Allen Wealth Management's portfolio in Q3 2026, its #16 holding.
  • Allen Wealth Management first reported a position in Medtronic in Q1 2024 and has held it in 11 quarters since.
  • 917 funds tracked by Wall St. Rank held Medtronic as of Q3 2026.

Based on Allen Wealth Management's 13F filing for Q3 2026, filed 29 Oct 2026.